Skip to main content

Day: August 16, 2023

TFI International Completes Previously Announced JHT Acquisition

MONTREAL, Aug. 16, 2023 (GLOBE NEWSWIRE) — TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, today announced that it has closed on the previously announced acquisition of JHT Holdings, Inc., a leading asset light logistics and transportation provider in North America for Class 6-8 truck manufacturers. ABOUT TFI INTERNATIONAL TFI International Inc. is a North American leader in the transportation and logistics industry, operating across the United States and Canada through its subsidiaries. TFI International creates value for shareholders by identifying strategic acquisitions and managing a growing network of wholly-owned operating subsidiaries. Under the TFI International umbrella, companies benefit from financial and operational resources to build their businesses...

Continue reading

StoneCo Reports Second Quarter 2023 Results

Strong Revenue Growth and Profits Above Expectations R$3 billion in Revenues, R$447 million in Adjusted EBT and R$322 million in Adjusted Net Income,a year over year growth of 28%, 489% and 477%, respectively GEORGE TOWN, Grand Cayman, Aug. 16, 2023 (GLOBE NEWSWIRE) — StoneCo Ltd. (Nasdaq: STNE, B3: STOC31) (“Stone” or the “Company”) today reports its financial results for its second quarter ended June 30, 2023. Operating and Financial Highlights for 2Q23 Note about our non-IFRS Adjusted P&L metrics: as anticipated in our 4Q22 Earnings announcement, from 1Q23 onwards we no longer adjust the expenses related to share-based compensation, which may affect the comparability of our current Adjusted results to our Adjusted numbers prior to 1Q23. To allow for better understanding of our business performance trends, the tables in...

Continue reading

Robinhood Markets, Inc. Reports July 2023 Operating Data

MENLO PARK, Calif., Aug. 16, 2023 (GLOBE NEWSWIRE) — Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported selected monthly operating data for July 2023:Net Cumulative Funded Accounts (NCFA) at the end of July were 23.2 million, up approximately 50 thousand from June 2023(1). Monthly Active Users (MAU) increased to 11.0 million in July, up approximately 200 thousand from June 2023.Assets Under Custody (AUC) at the end of July were $94.5 billion, up 6% from June 2023. Net Deposits were $1.4 billion in July, translating to a 19% annualized growth rate relative to June 2023 AUC. Over the last twelve months, Net Deposits were $16.8 billion, translating to an annual growth rate of 23% relative to July 2022 AUC.Trading Volumes in July were higher for equities and crypto and lower for options compared to June 2023....

Continue reading

Navigator Holdings Ltd. Preliminary Second Quarter 2023 Results (Unaudited)

NEW YORK and LONDON, Aug. 16, 2023 (GLOBE NEWSWIRE) — HighlightsOn August 15, 2023, the Board declared a cash dividend of $0.05 per share of the common stock of Navigator Holdings Ltd. (the “Company”, “Navigator”, “we”, “our” and “us”) (NYSE: NVGS), for the quarter ended June 30, 2023 (the “Dividend”). The Dividend will be payable on September 22, 2023, to all shareholders of record as of the close of business New York time on September 8, 2023 which would have equated to a quarterly dividend payment of $3.7 million. As part of the Capital Return Policy for the quarter ended June 30, 2023, Navigator expects to repurchase approximately $3.0 million of the Company’s common stock (the “Share Repurchases”) between now and the quarter ending September 30, 2023, subject to operating needs, market conditions and other circumstances,...

Continue reading

Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update

Operating Expenses Decreased 31% Quarter Over Quarter and 25% Year to Date,Reflecting Cost Cutting Initiatives Management to Host Conference Call Today at 6:00 pm ET LITTLETON, Colo., Aug. 16, 2023 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing related sleep conditions arising from certain dentofacial abnormalities, today reported financial results and operating highlights for the second quarter and six months ended June 30, 2023. Second Quarter 2023 Financial and Operating SummaryRevenue was $3.4 million for the second quarter of 2023 and $7.3 million for the six months...

Continue reading

NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update

On Track to Present Data Updates from All Ongoing Clinical Studies in the Second Half of 2023 Well Capitalized with Anticipated Cash Runway into 2025 EDINBURGH, United Kingdom, Aug. 16, 2023 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) announced financial results for the second quarter ended June 30, 2023 and provided an update on its broad clinical development program with its transformative ProTide therapeutics. As of June 30, 2023, NuCana had cash and cash equivalents of £24.6 million compared to £31.0 million at March 31, 2023 and £41.9 million at December 31, 2022. NuCana continues to advance its various clinical programs and reported a net loss of £5.4 million for the quarter ended June 30, 2023, as compared to a net loss of £3.9 million for the quarter ended June 30, 2022. Basic and diluted loss per share was £0.10 for the...

Continue reading

Meritage Announces Third Quarter Dividend: and 7 Brew Coffee Development Opportunity

GRAND RAPIDS, Mich., Aug. 16, 2023 (GLOBE NEWSWIRE) — Meritage Hospitality Group Inc. (OTCQX: MHGU), the nation’s premier franchise operator, announced today the Company’s Board of Directors approved a quarterly special dividend of $0.09 per share. The dividend is payable on October 1, 2023, to shareholders of record as of September 15, 2023. The Board also authorized the Company to proceed with final due diligence to engage as a franchisee to develop and operate 7 Brew Coffee drive-thru locations in the Mid-West. The preliminary terms of the agreement call for the Company to build up to 64 restaurant locations by the end of 2030. 7 Brew Coffee is a double drive thru concept, rolling out across the U.S. with many trade areas currently committed for development by franchisees. The 7 Brew concept is part of the Company’s plan for...

Continue reading

Complete Solaria to Host Second Quarter & Business Update Call on August 22, 2023

FREMONT, Calif., Aug. 16, 2023 (GLOBE NEWSWIRE) — Complete Solaria, Inc. (“Complete Solaria” or the “Company”) (Nasdaq: CSLR), a leading solar technology, services, and installation company, today announced it will host a one-hour call on Tuesday, August 22, 2023 at 5:00pm ET, to review Q2 results and the residential solar market. The formal presentation will be followed by a live question and answer session. Registration is required for this virtual event. To register, click HERE. The presentation materials, as well as a replay of the webcast, will be available following the event on the Complete Solaria Investors page, located at https://investors.completesolaria.com/. About Complete SolariaComplete Solaria is a solar company with unique technology and an end-to-end customer offering, which includes financing, project fulfilment,...

Continue reading

Medigene to participate in the H.C. Wainwright Immune Cell Engager Virtual Conference

Planegg/Martinsried, August 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will be participating in the H.C. Wainwright Immune Cell Engager Virtual Conference on August 17, 2023. Members of Medigene’s management team will participate in a fireside chat and will be available for virtual one-on-one meetings with registered investors.—  end of press release  — About Medigene Medigene AG (FSE: MDG1) is an immuno-oncology platform company dedicated to developing T cell therapies to effectively eliminate cancer. Its end-to-end technology platform, built on multiple proprietary and exclusive product development and product enhancement technologies, allows Medigene to create best-in-class...

Continue reading

Global Precast Concrete Market Size to Reach USD 154.89 Billion in 2030 | Emergen Research

Increasing investments in infrastructure is one of the key factors driving Precast Concrete market revenue growth. Vancouver, Aug. 16, 2023 (GLOBE NEWSWIRE) — As per the latest comprehensive analysis by Emergen Research, the precast concrete market achieved a substantial magnitude, attaining a valuation of USD 95.20 Billion in 2021. The market’s trajectory remains poised for continuous growth, with a projected revenue compound annual growth rate (CAGR) of 5.7% during the forecast period. This dynamic expansion is underpinned by escalating investments in infrastructure, a pivotal driver propelling the market’s revenue ascent. The robust revenue growth is fortified by two principal catalysts: the rapid pace of urbanization and the exponential surge in global population. These transformative forces have set the stage for...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.